Core Laboratories Sees Q1 GAAP EPS $0.11-$0.15 vs $0.15 Est; Sees Sales $124.000M-$130.000M vs $128.290M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Core Laboratories (NYSE:CLB) is looking for Q1 GAAP EPS of $0.11-$0.15 vs $0.15 analyst estimate. sees sales of $124.000 million-$130.000 million vs $128.290 million analyst estimate.
Core Laboratories (NYSE:CLB) is looking for Q1 GAAP EPS of $0.11-$0.15 vs $0.15 analyst estimate. sees sales of $124.000 million-$130.000 million vs $128.290 million analyst estimate.